Evidence map›Paper›PMID 19815509›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Miz1 is a signal- and pathway-specific modulator or regulator (SMOR) that suppresses TNF-alpha-induced JNK1 activation.

Jing Liu, Yingming Zhao, Martin Eilers, Anning Lin

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Cells · 2018
    Article
  3. Ubiquitination by HUWE1 in tumorigenesis and beyond.Journal of biomedical science · 2018
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The role of MIZ-1 in MYC-dependent tumorigenesis.Cold Spring Harbor perspectives in medicine · 2013
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. E3 ubiquitin ligase Mule ubiquitinates Miz1 and is required for TNFalpha-induced JNK activation.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jing LiuBen May Department for Cancer Research, University of Chicago, Chicago, IL 60637, USA. jing@northwestern.edu
Yingming Zhao
Martin Eilers
Anning Lin

Funding

Integration of TNF Signaling in ApoptosisR01CA100460 · NCI · UNIVERSITY OF CHICAGO · PI LIN, ANNING · 2003 to 2010
$2.2M
Wiring the UV Signaling CircuitryR01ES015868 · NIEHS · UNIVERSITY OF CHICAGO · PI LIN, ANNING · 2008 to 2012
$1.7M
The JNK Signalsome and its FunctionsR01GM081603 · NIGMS · UNIVERSITY OF CHICAGO · PI LIU, JING · 2008 to 2012
$1.5M
Targeting BAD by JNK for Cell SurvivalR01GM071409 · NIGMS · UNIVERSITY OF CHICAGO · PI LIN, ANNING · 2006 to 2009
$1.1M
NCI NIH HHS CA100460NCI NIH HHS R01 CA100460NIEHS NIH HHS ES015868NIEHS NIH HHS R01 ES015868NIGMS NIH HHS GM071409NIGMS NIH HHS GM081603NIGMS NIH HHS R01 GM071409NIGMS NIH HHS R01 GM081603
6 · The paper itself

Abstract

The proinflammatory cytokine TNF-alpha exerts its pleiotropic functions through activation of multiple downstream effectors, including JNK1. Yet, the underlying regulatory mechanism is incompletely understood. Here, we report that the transcription factor Myc-interacting zinc-finger protein 1 (Miz1) selectively suppresses TNF-alpha-induced JNK1 activation and cell death independently of its transcription activity. Proteomics analysis and yeast two-hybrid screening reveal that Miz1 is a JNK-associated protein. The TNF-alpha-induced activation of JNK1 is augmented in Miz1-deficient mouse embryonic fibroblasts (Miz1(-/-) MEFs), but the augmentation is abrogated by reintroduction of Miz1 or its transcription-deficient mutant. The regulation by Miz1 is highly specific, because it regulates TNF-alpha-induced TRAF2 K63-linked polyubiquitination. Neither JNK1 activation by IL-1beta or UV nor TNF-alpha-induced activation of p38, ERK, or IkappaB kinase complex is affected by the loss of Miz1. The TNF-alpha-induced cell death also is accelerated in Miz1(-/-) MEFs. Upon TNF-alpha stimulation, Miz1 is degraded rapidly by the proteasome, relieving its suppression on JNK1 activation. Thus, our results show that in addition to being a transcription factor Miz1 acts as a signal- and pathway-specific modulator or regulator that specifically regulates TNF-alpha-induced JNK1 activation and cell death.

Indexed as

ApoptosisSignal TransductionAdaptor Proteins, Signal TransducingAmino Acid SequenceAnimalsEnzyme ActivationExtracellular Signal-Regulated MAP KinasesHumansI-kappa B KinaseKruppel-Like Transcription FactorsMiceMice, KnockoutMitogen-Activated Protein Kinase 8Nuclear Proteinsp38 Mitogen-Activated Protein KinasesProteasome Endopeptidase ComplexAdaptor Proteins, Signal TransducingExtracellular Signal-Regulated MAP KinasesI-kappa B KinaseKruppel-Like Transcription FactorsMitogen-Activated Protein Kinase 8Miz1 protein, mouseNuclear Proteinsp38 Mitogen-Activated Protein KinasesProteasome Endopeptidase ComplexProtein Inhibitors of Activated STATT2bp protein, mouseTumor Necrosis Factor-alphaUbiquitin-Protein LigasesZBTB17 protein, human

Identifiers

PMID19815509
PMCPMC2775337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.